Pharmacogenomic Testing May Curb Drug Interactions in MDD

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized clinical trial that included almost 2000 adults with MDD, patients in the pharmacogenomics-guided group were more likely to receive an antidepressant that had no drug-gene interaction than the patients … Read more

Psychedelics’ Interaction With Psych Meds: More Q’s Than A’s

Psychedelics, including psilocybin and MDMA, are promising for a variety of psychiatric disorders, but there are few data showing how these drugs interact with traditional psychiatric medications, new research shows. “Despite prolific psychedelic research and public interest, I was surprised to see little clinical research on how psilocybin and common psychiatric treatments interact,” study investigator … Read more